Skip to main navigation
Decibel Therapeutics logo
Menu Button

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
March 1, 2021 SC 13G

A statement of beneficial ownership of common stock by certain persons

0001104659-21-029968.pdf
0001104659-21-029968.rtf
0001104659-21-029968.xls
View HTML
January 13, 2017 D/A

Amend: Notice of Exempt Offering of Securities

0001656536-17-000002.pdf
0001656536-17-000002.rtf
View HTML
January 28, 2021 S-1/A

Amended Registration statement for face-amount certificate companies

0001193125-21-020896.pdf
0001193125-21-020896.rtf
0001193125-21-020896.xls
View HTML
February 3, 2021 S-1/A

Amended Registration statement for face-amount certificate companies

0001193125-21-027403.pdf
0001193125-21-027403.rtf
0001193125-21-027403.xls
View HTML
February 8, 2021 S-1/A

Amended Registration statement for face-amount certificate companies

0001193125-21-031447.pdf
0001193125-21-031447.rtf
0001193125-21-031447.xls
View HTML
January 12, 2021 DRS/A

Amendment to a previously filed DRS

0000950123-21-000285.pdf
0000950123-21-000285.rtf
0000950123-21-000285.xls
View HTML
February 19, 2021 3/A

An amendment to a 3 filing. Non-EDGAR filing

0000899243-21-007428.pdf
0000899243-21-007428.rtf
0000899243-21-007428.xls
View HTML
December 11, 2020 DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

0000950123-20-012596.pdf
0000950123-20-012596.rtf
0000950123-20-012596.xls
View HTML
February 11, 2021 EFFECT

EFFECT

9999999995-21-000599.pdf
9999999995-21-000599.rtf
9999999995-21-000599.xls
View HTML
March 2, 2021 SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

0000947871-21-000278.pdf
0000947871-21-000278.rtf
0000947871-21-000278.xls
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 52 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2021. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us